Royal Bank Of Canada Adma Biologics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 225,465 shares of ADMA stock, worth $4.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

225,465

Previous 28,021 704.63%

Holding current value

$4.82 Million

Previous $313,000 1339.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $2.21 Million - $3.95 Million	197,444 Added 704.63%	225,465 $4.51 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $103,848 - $194,151	17,366 Added 162.98%	28,021 $313,000
Q1 2024 Nov 05, 2024	SELL	$4.4 - $6.74 $76,410 - $117,046	-17,366 Reduced 61.97%	10,655 $70,000
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $213,870 - $327,611	-48,607 Reduced 82.02%	10,655 $70,000
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $87,302 - $128,119	28,345 Added 91.68%	59,262 $267,000
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $13,782 - $18,310	3,972 Added 14.74%	30,917 $110,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $47,261 - $63,924	15,148 Added 128.41%	26,945 $99,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $36,062 - $46,366	-11,981 Reduced 50.39%	11,797 $39,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $39,181 - $61,548	15,863 Added 200.42%	23,778 $92,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $2,572 - $3,623	1,267 Added 19.06%	7,915 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $66,688 - $102,597	-46,635 Reduced 87.52%	6,648 $13,000
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $68,202 - $97,507	53,283 New	53,283 $97,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $4,572 - $6,963	-4,195 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $3,505 - $5,118	-3,102 Reduced 42.51%	4,195 $5,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.07 $11,018 - $15,104	7,297 New	7,297 $11,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.2B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Adma Biologics, Inc. Transaction History